| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 428,0 k € | +31.0% | 326,6 k € | +12.5% | 290,3 k € | +11.9% | 259,3 k € | -20.1% | 324,3 k € | +38.4% | 234,4 k € | -26.2% | 317,7 k € | +45.6% | 218,1 k € | +12.9% | 193,3 k € | +11.3% | 173,7 k € | -2.8% | 178,7 k € | +11.9% | 159,7 k € | -21.2% | 202,6 k € | +37.0% | 147,9 k € | -21.3% | 187,8 k € | +125.9% | 83,1 k € | -61.2% | 214,1 k € | +117.9% | 98,2 k € | -60.1% | 246,0 k € | |
| EBITDA | 421,9 k € | +31.7% | 320,3 k € | +12.5% | 284,6 k € | +12.6% | 252,8 k € | -20.2% | 316,7 k € | +36.4% | 232,2 k € | -25.6% | 312,3 k € | +46.1% | 213,8 k € | +14.0% | 187,5 k € | +10.4% | 169,7 k € | -2.5% | 174,1 k € | +10.9% | 157,0 k € | -21.5% | 200,0 k € | +119.8% | 91,0 k € | -50.0% | 181,8 k € | +135.6% | 77,2 k € | -60.5% | 195,3 k € | +326.5% | 45,8 k € | -67.6% | 141,4 k € | |
| Operating profit | 315,8 k € | +48.5% | 212,6 k € | +10.1% | 193,1 k € | +18.7% | 162,6 k € | -26.8% | 222,2 k € | +68.7% | 131,7 k € | -32.9% | 196,4 k € | +113.0% | 92,2 k € | +50.0% | 61,5 k € | +146.5% | 24,9 k € | -13.2% | 28,7 k € | -32.1% | 42,4 k € | -46.0% | 78,4 k € | +326.1% | -34,7 k € | -150.9% | 68,1 k € | +292.0% | -35,5 k € | -147.2% | 75,2 k € | +229.2% | -58,2 k € | -182.0% | 71,0 k € | |
| Profit/loss | 214,0 k € | +26.6% | 169,0 k € | +38.2% | 122,2 k € | +70.3% | 71,8 k € | -46.6% | 134,3 k € | +75.3% | 76,6 k € | -28.4% | 106,9 k € | +165.3% | 40,3 k € | +129.4% | 17,6 k € | +185.9% | -20,5 k € | -37.0% | -14,9 k € | +18.4% | -18,3 k € | -151.5% | 35,5 k € | +140.8% | -87,0 k € | -1561.2% | 6,0 k € | -78.9% | 28,2 k € | +6539.1% | 425,0 € | +102.8% | -15,2 k € | +85.1% | -102,5 k € | |
| Equity | 837,0 k € | +9.1% | 766,9 k € | +28.3% | 598,0 k € | +25.7% | 475,7 k € | +17.8% | 404,0 k € | +49.8% | 269,6 k € | +39.7% | 193,0 k € | -38.0% | 311,1 k € | +14.9% | 270,8 k € | +6.9% | 253,2 k € | -7.5% | 273,7 k € | -5.2% | 288,6 k € | -13.0% | 331,9 k € | +12.0% | 296,4 k € | -22.7% | 383,4 k € | -33.6% | 577,5 k € | +5.1% | 549,3 k € | +0.1% | 548,8 k € | -2.7% | 564,1 k € | |
| Total assets | 1,1 M € | +3.2% | 1,1 M € | +19.0% | 920,8 k € | +3.5% | 889,8 k € | -9.9% | 987,7 k € | -0.5% | 992,7 k € | -6.3% | 1,1 M € | -3.1% | 1,1 M € | -8.6% | 1,2 M € | -7.0% | 1,3 M € | -8.4% | 1,4 M € | -1.8% | 1,4 M € | -9.9% | 1,6 M € | -4.3% | 1,7 M € | +7.9% | 1,5 M € | -3.4% | 1,6 M € | -4.0% | 1,7 M € | -0.3% | 1,7 M € | +0.2% | 1,7 M € | |
| Cash | 206,5 k € | +31.7% | 156,8 k € | +376.0% | 32,9 k € | -24.2% | 43,5 k € | -31.1% | 63,1 k € | -20.6% | 79,5 k € | +136.1% | 33,7 k € | +45.7% | 23,1 k € | +58.1% | 14,6 k € | +176.4% | 5,3 k € | -60.3% | 13,3 k € | -50.1% | 26,7 k € | -70.7% | 91,0 k € | +48.9% | 61,1 k € | -62.3% | 162,3 k € | +8.1% | 150,2 k € | -16.6% | 180,0 k € | -20.2% | 225,5 k € | -56.8% | 522,0 k € | |
| Debts | 279,3 k € | -15.1% | 329,2 k € | +2.0% | 322,8 k € | -22.0% | 414,0 k € | -29.1% | 583,8 k € | -19.2% | 722,1 k € | -15.5% | 854,9 k € | +11.3% | 768,2 k € | -15.8% | 912,5 k € | -10.3% | 1,0 M € | -10.1% | 1,1 M € | -0.9% | 1,1 M € | -9.1% | 1,3 M € | -7.9% | 1,4 M € | +18.1% | 1,2 M € | +13.8% | 1,0 M € | -8.5% | 1,1 M € | -0.5% | 1,1 M € | +1.7% | 1,1 M € | |
Private company with limited liability · Maldegem · incorporated on 16/07/1999
Private company with limited liability profitable and well capitalised. Cash position rising (+31.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. FRANK PROVENIER CARDIOLOOG is a Private company with limited liability incorporated in 1999. Its main activity is: Specialist medical practice activities. Its registered office is in Maldegem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette